Showing results (11-20 of 4,420) with videos related to
Sort By:
Pageof 442
Dermatology (Basel, Switzerland)|January 4, 2011
COL7A1 Recessive mutations in two siblings with distinct subtypes of dystrophic epidermolysis bullosa: pruriginosa versus nails onlySara Pruneddu, Daniele Castiglia, Giovanna Floriddia, et al.Dermatology (Basel, Switzerland)|February 25, 2011
Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitorsPeter A Gerber, Gabriela Kukova, Bettina A Buhren, et al.Dermatology (Basel, Switzerland)|February 25, 2011
Panton-Valentine leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infectionsPascal Del Giudice, Michèle Bes, Thomas Hubiche, et al.Dermatology (Basel, Switzerland)|November 13, 2010
EpiDex® Swiss field trial 2004-2008Natalie Ortega-Zilic, Thomas Hunziker, Severin Läuchli, et al.Dermatology (Basel, Switzerland)|May 21, 2010
Human papillomavirus type 7-associated condylomaToshihiko Matsukura, Tsuyoshi Mitsuishi, Motoyasu Sugase, et al.Dermatology (Basel, Switzerland)|May 21, 2010
Development of two primary malignant melanomas after treatment with adalimumab: a case report and review of the possible link between biological therapy with TNF-alpha antagonists and melanocytic proliferationA C Katoulis, A Kanelleas, G Zambacos, et al.Dermatology (Basel, Switzerland)|August 25, 2010
The burden of nail psoriasis: an introductionRobert BaranDermatology (Basel, Switzerland)|August 25, 2010
Methods of outcomes measurement in nail psoriasisM Augustin, A OgilvieDermatology (Basel, Switzerland)|July 15, 2010
A common founder mutation in the EDA-A1 gene in X-linked hypodontiaMazen Kurban, Eleni Michailidis, Muhammad Wajid, et al.Dermatology (Basel, Switzerland)|July 15, 2010
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS TrialKristian Reich, Jean-Paul Ortonne, Urs Kerkmann, et al.Pageof 442